Acadia Pharmaceuticals
1,054 employees on LinkedIn · 1 known investors
Acadia is a biopharmaceutical company developing novel therapies for neurological disorders and rare diseases, focused on patients and families with few or no existing treatment options. It also runs a medical affairs function serving U.S. healthcare professionals and pursues research partnerships.
Investors · 1
Frequently asked questions
- What does Acadia Pharmaceuticals do?
- Acadia is a biopharmaceutical company developing novel therapies for neurological disorders and rare diseases, focused on patients and families with few or no existing treatment options. It also runs a medical affairs function serving U.S. healthcare professionals and pursues research partnerships.
- Who are Acadia Pharmaceuticals's investors?
- Acadia Pharmaceuticals's investors include New Enterprise Associates (NEA).